In Vivo Carbon-13 Dynamic MRS and MRSI of Normal and Fasted Rat Liver with Hyperpolarized 13C-Pyruvate by Hu, Simon et al.
B The Author(s), 2009
Published Online: 8 May 2009 DOI: 10.1007/s11307-009-0218-z
Mol Imaging Biol (2009) 11:399Y407
RESEARCH ARTICLE
In Vivo Carbon-13 Dynamic MRS and MRSI
of Normal and Fasted Rat Liver
with Hyperpolarized
13C-Pyruvate
Simon Hu,
1,2 Albert P. Chen,
3 Matthew L. Zierhut,
1,2 Robert Bok,
1 Yi-Fen Yen,
3
Marie A. Schroeder,
4 Ralph E. Hurd,
3 Sarah J. Nelson,
1,2 John Kurhanewicz,
1,2
Daniel B. Vigneron
1,2
1Department of Radiology and Biomedical Imaging, University of California, San Francisco, Box 2512 1700 4th St. QB3 Building, Suite
102, San Francisco, CA 94158-2512, USA
2UCSF & UCB Joint Graduate Group in Bioengineering, Berkeley, CA, USA
3GE Healthcare, Menlo Park, CA, USA
4Department of Physiology, University of Oxford, Oxford, UK
Abstract
Background: The use of in vivo
13C nuclear magnetic resonance spectroscopy in probing
metabolic pathways to study normal metabolism and characterize disease physiology has been
limited by its low sensitivity. However, recent technological advances have enabled greater than
50,000-fold enhancement of liquid-state polarization of metabolically active
13C substrates,
allowing for rapid assessment of
13C metabolism in vivo. The present study applied hyper-
polarized
13C magnetic resonance spectroscopy to the investigation of liver metabolism,
demonstrating for the first time the feasibility of applying this technology to detect differences in
liver metabolic states.
Procedures: [1-
13C]pyruvate was hyperpolarized with a dynamic nuclear polarization instrument
and injected into normal and fasted rats. The uptake of pyruvate and its conversion to the
metabolic products lactate and alanine were observed with slice-localized dynamic magnetic
resonance spectroscopy and 3D magnetic resonance spectroscopic imaging (3D-MRSI).
Results: Significant differences in lactate to alanine ratio (PG0.01) between normal and fasted
rat liver slice dynamic spectra were observed. 3D-MRSI localized to the fasted livers
demonstrated significantly decreased
13C-alanine levels (PG0.01) compared to normal.
Conclusions: This study presents the initial demonstration of characterizing metabolic state
differences in the liver with hyperpolarized
13C spectroscopy and shows the ability to detect
physiological perturbations in alanine aminotransferase activity, which is an encouraging result
for future liver disease investigations with hyperpolarized magnetic resonance technology.
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I
mproved monitoring and measurement of metabolism in
key biological processes, such as glycolysis and the citric
acid cycle, both in the presence and absence of disease, have
been long-sought goals in the molecular and medical
imaging communities. In particular, there has been great
interest in pursuing carbon-13 nuclear magnetic resonance
spectroscopy as a means of probing metabolic pathways to
study normal metabolism and characterize disease physiol-
ogy [1–3]. While these in vivo studies of either endogenous
or enriched
13C compounds have proven fruitful, such
experiments have suffered from unique technical challenges,
the most severe of which is low signal sensitivity, resulting
in long acquisition times and large voxel sizes to obtain
spectra with adequate signal-to-noise ratios (SNR) [1–3].
However, a recent technological breakthrough, namely the
development of techniques to maintain hyperpolarization of
carbon-13 substrates in liquid state [4–5], has generated
significant excitement for the prospect of rapid high signal-
to-noise measurement of
13C metabolism in vivo. Hyperpo-
larization [4–5] was achieved through the dynamic nuclear
polarization (DNP) effect and thermal cooling, and liquid-
state (compatible with in vivo injection) polarization in
excess of 50,000-fold was preserved using a novel rapid
heated dissolution process. The use of carbon-13-enriched
substrates as molecular imaging agents with this technique is
also attractive because
13C is not radioactive and is only
slightly heavier than carbon endogenous to the body,
causing no significant isotope effects.
Initial applications of this technology were primarily
focused on tracer-based angiography [6] and perfusion
mapping [7]. More recent studies have included metabolic
molecular imaging, using the metabolically active substrate
[1-
13C]pyruvate to examine its conversion to [1-
13C]lactate,
[1-
13C]alanine, and
13C-bicarbonate [8–12]. Fig. 1 provides
a simplified summary of the metabolic pathways studied in
vivo with hyperpolarized [1-
13C]pyruvate. (Note: LDH can
also be found in the mitochondria [13].) This hyperpolarized
metabolic imaging approach enables not only the detection
of the uptake of the injected prepolarized substrate such as
pyruvate but also its conversion to lactate or alanine due to
rapid exchange of the
13C label [12] as catalyzed by lactate
dehydrogenase (LDH) and alanine aminotransferase (ALT),
respectively. In prior studies, significantly higher levels of
[1-
13C]lactate were found in implanted mouse tumors [9, 12]
and tumors in a mouse model of prostate cancer [11], which
can be explained by the hyperglycolytic state and increased
LDH activity common to most cancers [14–15]. Further-
more, it was demonstrated that the rate constant for LDH
flux decreased after drug treatment in an implanted tumor
model [12]. Thus, using hyperpolarized magnetic resonance
imaging (MRI) technology to monitor LDH-mediated lactate
conversion could ultimately become a clinically viable
metabolic molecular imaging method for measuring disease
progression and tumor response to therapy as a complemen-
tary addition to anatomic imaging and
1H magnetic
resonance spectroscopy (MRS)/magnetic resonance spectro-
scopic imaging (MRSI). In cardiac research with isolated rat
heart and in vivo experiments, others have demonstrated the
ability of hyperpolarized
13C to directly evaluate pyruvate
Fig. 1. Diagram of metabolic pathways investigated with DNP hyperpolarized [l-
13C]-pyruvate. Pyruvate/lactate conversion is
catalyzed by lactate dehydrogenase (LDH), and pyruvate/alanine conversion is catalyzed by alanine transaminase (ALT).
Pyruvate is irreversibly converted to acetyl-CoA and CO2 by pyruvate dehydrogenase (PDH), and CO2 is in a pH-dependent
equilibrium with bicarbonate.
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sion [16–17]. PDH flux is a key step in normal and diseased
cardiac metabolism, and there has been an initial report of
altered bicarbonate levels during ischemia in the pig heart
[18] and in a rat model of diabetes [17]. Although all of the
above metabolic imaging studies used [1-
13C]pyruvate,
hyperpolarization of other molecular agents is also possible.
For example, hyperpolarized [1-
13C]lactate can be used to
examine the LDH back reaction [19]. In addition, hyper-
polarized bicarbonate (H
13CO3–), which converts to
13CO2
in a pH-dependent manner governed by the reaction
catalyzed by the enzyme carbonic anhydrase, can be used
to image pH [20], and this has great clinical potential
because many disease processes, such as cancer, exhibit
abnormal pH [21]. Hyperpolarization of yet other molecular
imaging agents to explore various other metabolic pathways
is being actively researched.
The initial research studies applying hyperpolarized
13C
metabolic imaging have focused on animal studies of cancer
and cardiac metabolism. Thus far, there have been no
published reports focusing on the investigation of liver
metabolism with hyperpolarized
13C technology. Therefore,
the goals of this study were to characterize normal liver
metabolism with hyperpolarized
13C slice-localized dynamic
spectroscopy and 3D-MRSI and to investigate the ability of
this technique to detect a change in metabolic state,
specifically fasting. Whereas others have isolated changes
based on LDH and PDH activity, in this work, we aimed to
focus on detection of alanine levels following injection of
hyperpolarized pyruvate to probe ALT activity in the fasted
state. Serum ALT levels have been known to change in
many liver diseases [22], so therefore ALT-mediated flux
could be an additional biomarker of interest for liver disease.
Materials and Methods
The overall process for the hyperpolarized imaging experiments
was as follows: prepare a sample to be polarized, polarize with a
DNP polarizer, perform anatomical imaging of the rat while waiting
for the polarization to build up, dissolve and eject a liquid sample
from the polarizer, inject the sample into a rat inside a clinical
magnetic resonance (MR) scanner, and perform either slice
dynamic spectroscopy or 3D-MRSI. A total of 20 rat experiments
were conducted (five normal dynamic, five fasted dynamic, five
normal MRSI, five fasted MRSI).
Polarizer and Preparations
A HyperSense DNP polarizer (Oxford Instruments, Abingdon, UK)
was used in this study. Following previously described methods
[4–5], 32 μL (about 40 mg) of [1-
13C]pyruvic acid (Isotec,
Miamisburg, OH, USA) with 15 mM OX63 trityl radical (Oxford
Instruments, Abingdon, UK) was polarized in a field of 3.35 T at
approximately 1.4 K by irradiation with 94.116-GHz microwaves.
After approximately 1 h when the solid-state polarization neared its
exponential asymptote, an aqueous solution with 5.96 g/L Tris
(40 mM), 4.00 g/L NaOH (100 mM), and 0.1 mg/L Na2
ethylenediaminetetraacetate acid was injected into the DNP polar-
izer, heated, and used for rapid thawing and dissolution of the
solid-state sample. The amounts of solvent, NaOH, and Tris buffer
used were calculated to produce a final polarized sodium pyruvate
concentration of 100 mM and a pH of approximately 7.6. After the
rapid thawing, the dissolved material was ejected into a flask
resting on ice. Immediately thereafter, a small aliquot (∼0.5 mL) of
the hyperpolarized [1-
13C]pyruvate solution was used to measure
the level of polarization achieved in solution, and at the same time
another ∼2.4 mL was taken to the MR scanner to be injected into a
rat over a 12-s period followed by a normal saline flush.
Animal Handling
All animal studies were carried out under a protocol approved by
the University of California San Francisco Institutional Animal
Care and Use Committee. Male Sprague-Dawley rats weighing
∼300 g were either allowed to feed freely on standard rat chow
(normal, nonfasted) or had their food removed 24 h before each
hyperpolarized study (fasted). For each experiment, the rat was
placed on a heated pad and anesthetized with isoflurane (2–3%). A
catheter was introduced into the tail vein for the eventual intravenous
administration of hyperpolarized pyruvate solution, and the rat was
transferred to a heated pad in the radio frequency (RF) coil in the MR
scanner. While in the scanner, anesthesia was maintained by a
continual delivery of isoflurane (1–2%) via a long tube to a nose
cone, with an oxygen flow of 1 L/min. The rat’svital signs(heart rate
and oxygen saturation) were continually monitored. Care was taken
to ensure that body temperature was maintained at 37°C throughout
the imaging procedures by maintaining a flow of heated water
through the pad underneath the rat.
MRI, MRS, and MRSI Studies
All studies were performed using a 3T GE Signa™ scanner (GE
Healthcare, Waukesha, WI, USA) equipped with the multinuclear
spectroscopy hardware package. The RF coil used in these
experiments was a dual-tuned
1H–
13C coil with a quadrature
13C
channel and linear
1H channel construction based on an earlier
design [23] and used in prior hyperpolarized
13C pyruvate rat
imaging studies [10]. The inner coil diameter was 8 cm, and the
length of the coil was 9 cm to accommodate rats of varying size.
T2-weighted anatomical images were obtained in all three planes
using a fast spin-echo sequence. Axial and sagittal images were each
acquired in approximately 10 min with a 10-cm field of view (FOV),
192×192 matrix, 2-mm-thick slices and NEX=6. Coronal images
were acquired with a 12-cm FOV, 192×192 matrix, 1.5-mm-thick
slices and NEX=6 with a scan time of 10 min. The total imaging time
required to obtain images in all three planes was thus approximately
30 min.
For the slice localized liver dynamic MRS experiments, a double
spin-echo pulse sequence with a 5° flip selective RF excitation pulse
(15-mm axial slice localization) and a pair of nonlocalized 180°
hyperbolic secant refocusing pulses was used [24]. A TE of 35 ms
(half-echo collected), a repetition time (TR) of 3 s, and a readout
filter of 5,000 Hz/2,048 pts were used for these studies. The
acquisitionlocalizedtoaslicethroughtheliverstartedatthebeginning
of a 12-s manual injection of [1-
13C]pyruvate into the rat tail vein.
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13C-lactate and
13C-alanine peak
heights were important parameters in the final processed dynamic curves (left). The areas of hyperpolarized
13C resonances in
the 3D-MRSI spectra were used in quantitative comparisons (right). The MRS example comes from data plotted in Fig. 3, and
the 3D-MRSI example comes from a voxel from Fig. 5.
Fig. 3. Comparison of normal (top) and fasted (bottom) rat liver representative dynamic data. The final processed dynamic
curves were derived from the stack plots (left). The alanine and lactate levels were similar in the normal rat liver case (top right),
but lactate levels were much higher than alanine levels in the fasted rat liver case (bottom right).
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13C MRSI data were acquired in 14 s (starting 25 s after
the start of injection) with a slab-selective variable small tip angle
excitation pulse, double spin-echo refocusing pulses, and a flyback
echo-planar readout trajectory [11, 24]. An 8×8 phase encoding
matrix with a flyback echo-planar trajectory on the z-axis (8×8×16
effective matrix) was used with 10×10×10-mm spatial resolution
(1.0-cm
3 voxel resolution) with an 80×80×160-mm FOV to cover
the rat torso and abdomen. The flyback echo-planar trajectory was
designed for a 581-Hz spectral bandwidth to include
13C lactate,
13C alanine, and
13C pyruvate without spectral aliasing. A total of
59 readout/rewind lobes were included during each readout for a
spectral resolution of 9.83 Hz. With a readout filter of 25,000 Hz/
2,538 points, 16 k-space points were acquired during each TR [25].
The TE for the MRSI acquisition was 140 ms (readout was centered
on the center of the second spin-echo, full echo collected), and the TR
was 215 ms. Asdescribedpreviously[11], a variable flip angle (VFA)
scheme [26], with increasing flip angle over time to compensate for
the loss in hyperpolarized signal, was used in the in vivo experiments.
Reordering of phase encodes to collect data near the k-space origin
first was also employed as previously described [11].
Data Processing
Fig. 2 shows an example of the dynamic and spectral
parameters for data processingi nt h es l i c eM R Sa n d3 D - M R S I
experiments. The MRS example comes from data plotted in
Fig. 3, and the 3D-MRSI example comes from a voxel from
Fig. 5. Dynamic MRS data, processed with MATLAB™,w e r e
apodized in the time domain with a 10-Hz Lorentzian filter,
Fourier-transformed along thet i m ed i m e n s i o na n dt a k e nf r o m
the resulting magnitude spectra. Magnitude dynamic curves
were obtained for pyruvate, pyruvate-H2O, lactate, and alanine,
from which peak lactate to alanine ratios were derived (Fig. 2
left). A nonparametric statistical test (used to avoid any
normality assumptions), the Mann–Whitney rank-sum test,
was used to compare the peak lactate to alanine ratio between
normal and fasted groups. For 3D-MRSI acquisitions, the
reconstruction and analysis procedures, described previously
in more detail [11, 24], were carried out with specialized
custom MRSI software [27] as follows: (1) the raw flyback
data were subsampled and ordered to obtain a 4D matrix of k-
space data, (2) each FID was apodized and a linear phase
correction was applied to the spectral samples as described in
[25] to account for the tilted k-space trajectory characteristic of
the flyback readout, and (3) a 4D Fourier transform with zero
padding of the spectra was performed. From the processed 3D
magnitude spectral data, for each rat, the voxels localized to
nonvasculature liver tissue were identified from the proton
anatomical images and the
13C spectra with sufficient signal-to-
noise ratios (95) were quantified. For each liver voxel, the area
under the spectral resonances of pyruvate, pyruvate-H2O,
lactate, and alanine were calculated, with the sum of these
four areas defined as the total carbon area (Fig. 2 right).
Lactate area to total carbon area and alanine area to total
carbon area were calculated for each voxel and then averaged
over all selected liver voxels to derive the test statistics average
lactate to total carbon ratio and average alanine to total carbon
ratio. The Mann–Whitney rank-sum test was used to compare
these test statistics between normal and fasted groups.
Results
Dynamic MRS of Normal and Fasted Rat Liver
Fig. 3 shows representative dynamic curves from slices
localized to the livers of normal and fasted rats. These final
dynamic curves were derived from the stack plot insets in
which each horizontal line in a stack plot represents a
separate magnitude spectrum of the hyperpolarized species
collected every 3 s. For easier viewing, the pyruvate curve
has been scaled down by a factor of 4 and the nonmetaboli-
cally active pyruvate-hydrate, which is in equilibrium with
pyruvate, was omitted from the plots in Fig. 3. In the
dynamic curves, each marked point represents the intensity
of pyruvate (∼171 ppm), lactate (∼183 ppm), and alanine
(∼176 ppm) at that time point, i.e., a trace of those ridges in
the associated stack plot, showing the uptake and conversion
of pyruvate. Typically, the lactate and alanine curves
showed a plateau around 20–30 s after injection, meaning
the highest lactate and alanine SNR occurred in this range.
This is important for picking an imaging window for the 3D-
MRSI acquisitions, in which the SNR from each voxel is
lower than in the slices in the MRS experiments. Qualita-
tively, the lactate and alanine curves in the normal rats had
similar maximum amplitudes while there was a dramatic
difference in the fasted rats. Fig. 4 shows the peak lactate to
alanine ratios for normal (1.18±0.18, [1.27, 1.39, 1.21, 1.09,
0.91]) and fasted rats (1.82±0.40, [2.28, 2.23, 1.54, 1.42,
1.64]). Using a Mann–Whitney rank-sum test, there was a
statistically significant difference in lactate to alanine ratio
(PG0.01). Also, these data demonstrated no overlap between
the groups.
3D-MRSI of Normal and Fasted Rat Liver
Fig. 5 shows representative axial slices from 3D-MRSI
spectra with 1×1×1-cm voxel resolution of normal and
fasted rat liver (typically, the rat liver spans a couple of
slices). The proton images serve as anatomical references for
the spectra and show vasculature regions in addition to liver
parenchyma. All the fasted liver voxel spectra showed a high
lactate to alanine ratio. Fig. 6 shows the average lactate to
alanine ratios for normal (1.18±0.16, [1.42, 1.12, 1.24, 1.11,
0.99]) and fasted rats (1.78±0.15, [1.85, 1.56, 1.85, 1.94,
1.65]) in a manner similar to Fig. 4 except with 3D-MRSI
data. The Fig. 6 data corroborate the Fig. 4 data, providing
further evidence of an effect. In addition, the Fig. 6 data
show greater separation between the normal and fasted
groups and less spread within the groups, which was
probably due to selecting localized liver voxels instead of
using tissue from a whole slice for the analysis. Qualitatively
in the spectra, the liver lactate levels looked comparable
between the normal and fasted states, but alanine seemed
lower in the latter state. As described in the “Materials and
Methods” section, the average lactate area to total carbon area
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calculated for each rat. Fig. 7 shows these lactate fractions
(normal liver lactate to total carbon 0.22±0.026, [0.264,
0.207, 0.211, 0.200, 0.229]; fasted liver lactate to total carbon
0.23±0.045, [0.305, 0.232, 0.191, 0.212, 0.208]) and alanine
fractions (normal liver alanine to total carbon 0.19±0.008,
[0.186, 0.185, 0.184, 0.190, 0.202]; fasted liver alanine to
totalcarbon 0.13±0.026,[0.165, 0.146, 0.103, 0.110, 0.126]).
Using a Mann–Whitney rank-sum test, there was no statisti-
cally significant difference in lactate to total carbon area
between normal and fasted groups (P=0.42), but there was a
statistically significant difference in alanine to total carbon
area between normal and fasted groups (PG0.01). With the
small sample size and low power, it is hard to say with
complete certainty that fasting had no effect on lactate
fraction, but the means/overlap in the data were strongly
suggestive of lactate fraction being relatively constant for all
rats. However, the decrease in alanine was statistically
significant and specific, with no overlap between groups.
Discussion
There have been many recent reports that have shown
hyperpolarized
13C MR to be sensitive to physiological
perturbations in enzyme-mediated flux involving LDH [9,
11–12] and PDH [16–17]. In this work, we have demon-
strated that hyperpolarized
13C MR is also sensitive to
physiological perturbations in ALT flux and shown that it is
possible to detect changes in metabolism in the liver with
this technology. Day et al. [12] demonstrated that metabolic
Fig. 5. Comparison of representative liver slice spectra from 3D-MRSI acquisitions on normal (left) and fasted (right) rats. The
spectra from normal liver showed similar levels of
13C-lactate and
13C-alanine. The spectra from fasted liver showed relatively
lower levels of
13C-alanine.
Fig. 4. The data points and mean values for peak lactate to
alanine ratios are shown from normal and fasted rat MRS
slice acquisitions. Normal rat liver showed a significantly
lower lactate to alanine ratio (PG0.01) than fasted rat liver.
Mean/SD—(normal 1.18±0.18, fasted 1.82±0.40). Note:
triangular markers show the collected data points and the
square marker/error bars show the mean/standard errors.
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enzyme-mediated exchange of the
13C label, i.e., isotope
redistribution to endogenous pools of metabolites [12]. It
was specifically shown that the detected lactate spectra
reflected the existing pool size of endogenous lactate. This
study also demonstrated that, by adding more unlabeled
lactate to cells injected with hyperpolarized
13C pyruvate,
higher detected
13C lactate was observed due to transfer of
label to the unlabeled lactate pool [12]. It was also shown
that in vivo there was a decrease in detected lactate when the
NADH coenzyme for LDH was inhibited, meaning flux
toward lactate and thus transfer of hyperpolarized label to
lactate was inhibited [12].
Fig. 7. Lactate area to total carbon-13 fraction (left) and alanine area to total carbon-13 fraction (right) from 3D-MRSI studies
(averaged over liver voxels per rat) of normal and fasted liver. The lactate to total carbon ratio was similar between normal and
fasted groups, demonstrating that lactate levels were relatively constant. Mean/SD—(normal 0.22±0.026, fasted 0.23±0.045,
P=0.42). The alanine to total carbon ratio was significantly lower for fasted rat liver. Mean/SD—(normal 0.19±0.008, fasted
0.13±0.026, PG0.01). Note: triangular markers show the collected data points and the square marker/error bars show the mean
and standard errors. In addition, the five normal alanine to total carbon points overlap, thus obscuring some points.
Fig. 6. Lactate area to alanine area from 3D-MRSI studies
(averaged over liver voxels per rat) of normal and fasted liver.
Normal rat liver showed a significantly lower lactate area to
alanine area ratio (PG0.01) than fasted rat liver. These data
corroborate the dynamic MRS data, with the means match-
ing closely and indicating the same conclusion. Mean/SD—
(normal 1.18±0.16, fasted 1.78±0.15). (Note: triangular
markers show the collected data points and the square
marker/error bars show the mean/standard errors.)
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this study demonstrated that the level of
13C alanine produced
in the murine liver from hyperpolarized pyruvate under the
influence of ALT flux was sensitive to the physiologic
perturbation of fasting. This alteration in alanine levels is
supported by prior metabolic studies demonstrating that
alanine is the key substrate utilized during gluconeogenesis,
e.g., due to fasting [28]. Gluconeogenic alanine conversion
during fasting has also been shown in previous biochemical
investigations involving perfused rat liver [29–30]. By
infusing labeled alanine, Cohen [29] showed that alanine
utilization and glucose production increased according to the
degree of gluconeogenesis, specifically showing more glu-
cose production in 24-h fasted rats than in 12-h fasted rats and
the highest production in drug-induced diabetic rats. In
addition, Stromski et al. [31] observed in vivo glucose
production from alanine. Thus, the finding that alanine levels
changed during fasting has been demonstrated in prior
biochemical studies, but what is new in this study is the
demonstration that this alteration can be detected in vivousing
an MR metabolic imaging technique.
Hyperpolarized technology for the measurement of
13C
metabolic flux has many advantages, including high SNR,
virtually zero background signal, and large chemical shift
dispersion. The use of
13C molecular imaging agents has the
additional benefits of no radioactivity and no heavy isotope
effects (e.g., deuterium which has twice the molecular
weight of water). The method is general in the sense that
many metabolic pathways could be probed, especially with
the continued development of preparations for the hyperpo-
larization of agents other than pyruvate [19, 20]. Hyper-
polarized spectroscopy with
13C pyruvate can be viewed as a
pyruvate challenge experiment employing a non-steady-state
measurement after an injection of a pyruvate bolus well
exceeding physiological concentrations. Regardless of the
supraphysiological levels of the injected substrate, the
reactions involving pyruvate have already shown promise
in the assessment of glycolysis through LDH [9, 11–12] and
cardiac metabolism through PDH [16, 17]. The pyruvate to
lactate pathway is extremely important for cancer applica-
tions because of the high lactate flux found in most tumors
as dictated by the Warburg principle [15]. For liver disease,
flux through the ALT pathway might also have medical
relevance. Clinical liver function tests routinely use meas-
urements of ALT levels in the blood, with high levels
correlating with disease. For example, high serum ALT
levels (i.e., twofold to tenfold normal) can indicate hepatitis,
fatty liver, and hepatotoxicity [22]. The presumed mecha-
nism responsible for elevated levels of ALT is injury to
hepatocytes and the consequent leakage of ALT into the
bloodstream [22], making ALT levels dependent on the
degree of liver injury. This does not necessarily represent a
change in ALT concentrations in liver cells, but if there is
indeed altered ALT and alanine concentrations in the liver
resulting in altered flux of the
13C label to alanine, then
anatomically localized
13C metabolic imaging with hyper-
polarized pyruvate as the substrate could be a valuable
technique to probe these changes. Using a hyperpolarized
molecular probe to monitor changes in localized
13C alanine
distribution could potentially be a more specific assay than a
serum ALT test, which can be complicated by high ALT
levels occurring from nonhepatic causes [32]. Additionally,
using hyperpolarized [1-
13C]pyruvate to monitor ALT flux
may be a useful biomarker of disease progression and
response to therapy. The significant in vivo change in liver
metabolism during fasting observed in this study is an
exciting initial demonstration of the potential value for liver
hyperpolarized MR metabolic imaging, as well as an
encouraging result for future liver disease studies using
hyperpolarized MR.
Conclusions
Normal and fasted rat liver were characterized with hyper-
polarized
13C slice-localized dynamic magnetic resonance
spectroscopy and 3D magnetic resonance spectroscopic
imaging. Fasted rat liver showed significantly lower levels
of alanine in both the dynamic MRS and 3D-MRSI data,
demonstrating the feasibility of hyperpolarized MR technol-
ogy for detecting a change in metabolic state in the liver.
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